FDA Approves Semglee (insulin glargine-yfgn) as the First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes

SILVER SPRING, Md., July 28, 2021 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus. Semglee (insulin glargine-yfgn) is both biosimilar to, and interchangeable with (can be… Read More »

How relaxing COVID-19 restrictions could pave the way for vaccine resistance

Relaxing Covid-19 restrictions could pave the way for new vaccine-resistant virus mutations, according to researchers at the University of East Anglia and the Earlham Institute. A new article published today warns against relaxing Covid-19 restrictions prematurely. It describes how we are in an ‘arms race’ with the virus and how rising cases could provide opportunities… Read More »

11 Signs Your Pet Needs More Joint Support

As cats and dogs age, they are more likely to experience joint pain or discomfort. Joint pain, stiffness, and discomfort in older- and middle-aged pets are often caused by arthritis. Osteoarthritis is the most common joint ailment that affects adult dogs and cats, although adult pets can also experience joint pain from rheumatoid arthritis and… Read More »